Post-market Surveillance of Micorport CRM Cardiac Implantable Electronic Devices

NCT05694572 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 2500

Last updated 2024-01-17

No results posted yet for this study

Summary

The primary objective of the study is to assess the chronic safety of MicroPort CRM market-released systems.

Conditions

Interventions

DEVICE

Implantation of a CIED

Implantation of a CIED

Sponsors & Collaborators

  • MicroPort CRM

    lead INDUSTRY

Principal Investigators

  • Yann POEZEVARA, MSc · MicroPort CRM

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-10-30
Primary Completion
2031-06-15
Completion
2031-06-15

Countries

  • Portugal

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05694572 on ClinicalTrials.gov